Nadia Saavedra-Fuentes, Enrique Carmona-Montesinos, Gilberto Castañeda-Hernández, Israel Campos, Juan Carlos Castillo-Salinas, Javier Alberto Castillo-Tapia, Karla Guadalupe Del Castillo-Loreto, Juan Carlos Falcón-Martínez, Raquel Fuentes-García, Miguel Ángel García de León Guerrero, Victor García-García, Erika F Gómez-García, Rafael González-Toledo, Angélica Jaime, Kely Rely, Claudia Lerma, Luis E Morales-Buenrostro, Mateo Quilantan-Rodriguez, Adrián Rodriguez-Matías, Felipe Octavio Rojas-Rodriguez, Rafael Valdez-Ortiz, Michael Wasung, Berenice Ceron-Trujillo, Edgar Ramirez-Ramirez
BACKGROUND: Current treatment for chronic kidney disease (CKD) focuses on improving manifestations and delaying progression. Nutritional approaches play a crucial role in CKD management, and various supplements have become available. Ketoanalogues of amino acids (KAs), calcium citrate, and inulin have been proposed as suitable supplements, yet their widespread use has been limited due to insufficient evidence. This study aimed to generate general guidance statements on the appropriateness of these supplements through a RAND/UCLA consensus process...
September 2, 2024: Nutrients